<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9306979</journal-id>
<journal-id journal-id-type="pubmed-jr-id">8564</journal-id>
<journal-id journal-id-type="nlm-ta">Seizure</journal-id>
<journal-id journal-id-type="iso-abbrev">Seizure</journal-id>
<journal-title-group>
<journal-title>Seizure</journal-title>
</journal-title-group>
<issn pub-type="ppub">1059-1311</issn>
<issn pub-type="epub">1532-2688</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30321769</article-id>
<article-id pub-id-type="pmc">6261486</article-id>
<article-id pub-id-type="doi">10.1016/j.seizure.2018.09.010</article-id>
<article-id pub-id-type="manuscript">NIHMS1509611</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>DRAVET SYNDROME IN SOUTH AFRICAN INFANTS: TOOLS FOR AN EARLY DIAGNOSIS</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Esterhuizen</surname>
<given-names>Alina I.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<!--<email>alina.esterhuizen@uct.ac.za</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mefford</surname>
<given-names>Heather C.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<!--<email>hmefford@uw.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramesar</surname>
<given-names>Rajkumar S.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<!--<email>raj.ramesar@uct.ac.za</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Shuyu</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
<!--<email>shuyuwang94@gmail.com</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carvill</surname>
<given-names>Gemma L.</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
<!--<email>gemma.carvill@northwestern.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wilmshurst</surname>
<given-names>Jo M.</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
<xref ref-type="aff" rid="A7">g</xref>
<!--<email>jo.wilmshurst@uct.ac.za</email>-->
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Division of Human Genetics, Institute of Infectious Diseases and Molecular Medicine, Department of Pathology,
University of Cape Town, Cape Town, South Africa.</aff>
<aff id="A2"><label>b</label>National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.</aff>
<aff id="A3"><label>c</label>Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA USA.</aff>
<aff id="A4"><label>d</label>Department of General Medicine, Alfred Health, Victoria, Australia.</aff>
<aff id="A5"><label>e</label>Ken and Ruth Davee Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago,
IL, USA.</aff>
<aff id="A6"><label>f</label>Paediatric Neurology and Neurophysiology, Red Cross Childrenâ€™s War Memorial Hospital, Cape Town, South
Africa.</aff>
<aff id="A7"><label>g</label>School of Child and Adolescent Health, University of Cape Town, South Africa.</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author Contributions</p>
<p id="P2">AE: experiment design and analysis, article conception, drafting, collation of information, critical revision; GLC:
experiment design, analysis and critical revision; RR: critical revision; SW: collation of clinical information; HCM: critical
revision; JW: patient recruitment, article conception, clinical insights, critical revision.</p>
</fn>
<corresp id="CR1"><bold>Corresponding author: Alina I. Esterhuizen</bold>, <email>alina.esterhuizen@uct.ac.za</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P34">Conflicts of Interests</p>
<p id="P35">The authors declare no conflicts of interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>62</volume>
<fpage>99</fpage>
<lpage>105</lpage>
<!--elocation-id from pubmed: 10.1016/j.seizure.2018.09.010-->
<abstract id="ABS1">
<sec id="S1">
<title>Purpose:</title>
<p id="P3">Dravet syndrome (DS) is a well-described, severe genetic epileptic encephalopathy with an increased risk of SUDEP. The
incidence and genetic architecture of DS in African patients is virtually unknown, largely due to lack of awareness and
unavailability of genetic testing. The clinical benefits of the available precision medicine approaches to treatment emphasise
the importance of an early, correct diagnosis. We investigated the genetic causes and clinical features of DS in South African
children to develop protocols for early, cost-effective diagnosis in the local setting.</p>
</sec>
<sec id="S2">
<title>Method:</title>
<p id="P4">We selected 22 South African children provisionally diagnosed with clinical DS for targeted resequencing of
DS-associated genes. We sought to identify the clinical features most strongly associated with <italic>SCN1A</italic>-related
DS, using the DS risk score and clinical co-variates under various statistical models.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P5">Disease-causing variants were identified in 10 of the 22 children: nine <italic>SCN1A</italic> and one
<italic>PCDH19</italic>. Moreover, we showed that seizure onset before 6 months of age and a clinical DS risk score of
&gt;6 are highly predictive of <italic>SCN1A</italic>-associated DS. Clinical reassessment resulted in a revised diagnosis
in 10 of the 12 variant-negative children.</p>
</sec>
<sec id="S4">
<title>Conclusion:</title>
<p id="P6">This first genetic study of DS in Africa confirms that <italic>de novo SCN1A</italic> variants underlie disease in the
majority of South African patients. Affirming the predictive value of seizure onset before 6 months of age and a clinical DS
risk score of &gt;6 has significant practical implications for the resource-limited setting, presenting simple diagnostic
criteria which can facilitate early correct treatment, specialist consultation and genetic testing.</p>
</sec>
</abstract>
<kwd-group>
<kwd>epilepsy</kwd>
<kwd>febrile seizures</kwd>
<kwd>epileptic encephalopathy</kwd>
<kwd>Sub-Saharan Africa</kwd>
<kwd>genetic epilepsy</kwd>
<kwd>
<italic>SCN1A</italic>
</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>